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Background: Little is known about how socioeconomic position (SEP) across life impacts on different
axes of the endocrine system which are thought to underlie the ageing process and its adverse conse-
quences. We examined how indicators of SEP across life related to multiple markers of the endocrine
system in late midlife, and hypothesized that lower SEP across life would be associated with an adverse
hormone proﬁle across multiple axes.
Methods: Data were from a British cohort study of 875 men and 905 women followed since their birth in
March 1946 with circulating free testosterone and insulin-like growth factor-I (IGF-I) measured at both
53 and 60e64 years, and evening cortisol at 60e64 years. Indicators of SEP were ascertained prospec-
tively across lifedpaternal occupational class at 4, highest educational attainment at 26, household
occupational class at 53, and household income at 60e64 years. Associations between SEP and hormones
were investigated using multiple regression and logistic regression models.
Results: Lower SEP was associated with lower free testosterone among men, higher free testosterone
among women, and lower IGF-I and higher evening cortisol in both sexes. For example, the mean
standardised difference in IGF-I comparing the lowest with the highest educational attainment at 26
years (slope index of inequality) was 0.4 in men (95% CI -0.7 to 0.2) and 0.4 in women (0.6
to 0.2). Associations with each hormone differed by SEP indicator used and sex, and were particularly
pronounced when using a composite adverse hormone score. For example, the odds of having 1 addi-
tional adverse hormone concentration in the lowest compared with highest education level were 3.7
(95% CI: 2.1, 6.3) among men, and 1.6 (1.0, 2.7) among women (P (sex interaction) ¼ 0.02). We found no
evidence that SEP was related to apparent age-related declines in free testosterone or IGF-I.
Conclusions: Lower SEP was associated with an adverse hormone proﬁle across multiple endocrine axes.
SEP differences in endocrine function may partly underlie inequalities in health and function in later life,
and may reﬂect variations in biological rates of ageing. Further studies are required to assess the likely
functional relevance of these associations.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).C1H 0AL, UK.
r Ltd. This is an open access article1. Introduction
Socioeconomic inequalities in premature mortality, as well as
physical and cognitive function are known to be substantial in the
UK and many other developed nations (Hurst et al., 2013;under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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known about the biological mechanisms which underlie these in-
equalities; that is, how exposure to socioeconomic conditions in
both early and adult life become embodied, leading to pathophys-
iological changes, impairment, disability and disease (Hertzman,
1999; Shonkoff et al., 2009).
The endocrine system, as assessed by circulating hormone
concentrations in multiple axes, is inﬂuenced by environmental
factors operating in both early and adult life, and has important
roles in regulating both early life development and adult health and
function (Ben-Shlomo et al., 2005; Cappola et al., 2007; Parekh
et al., 2010). For example, low testosterone has been associated
with adverse health outcomes among men, and high testosterone
has been linked to adverse outcomes among women. (Araujo et al.,
2011; Brand et al., 2011; Holland et al., 2011; O'Connell et al., 2011).
Low IGF-I has been related to worse physical and cognitive func-
tion, and both high and low IGF-I associated with increased risk of
cancer and cardiovascular mortality (Birnie et al., 2012; Burgers
et al., 2011; Westwood et al., 2014). Cortisol measures (including
a blunted ‘diurnal drop’) have also been associated with worse
physical function (Gardner et al., 2013). The endocrine system may
be especially important at older agesdchanges in both its regula-
tion and hormone production have been hypothesised to be key
potential mechanisms underlying the ageing process and its
adverse consequences (Chahal and Drake, 2007; Ferrucci and
Studenski, 2012; Hertoghie, 2005). For example, circulating IGF-I
and testosterone are thought to decline with age, while cortisol
concentrations may be higher at older ages (Bann et al., 2014b,
2015; Chahal and Drake, 2007; Kaufman and Vermeulen, 2005).
Differences in endocrine function, and in rates of age-related
changes, could therefore partly underlie socioeconomic in-
equalities in health and function. SEP may be related to an adverse
hormone proﬁle across multiple axes, which may have additive
and/or synergistic effects on physical and cognitive function in old
age (Cappola et al., 2009; Hertoghie, 2005). The causal nature of
hormone and health outcome relationships is not well-established
and may differ by outcome given the multiple actions of hormones
on different sites of the body. Not all observational studies have
found expected associations between hormones such as IGF-I or
cortisol and health-related outcomes (Singh-Manoux et al., 2014;
Stenholm et al., 2010). While there is consistent evidence from
trials in hypogonadal men that testosterone administration leads to
gains in muscle and/or losses in fat mass (Isidori et al., 2005), and
revitalised sexual function (Corona et al., 2014), a causal effect of
endogenous testosterone on cardiovascular disease risk was not
supported by a recent Mendelian randomisation study (Haring
et al., 2013). In addition to potential causal roles in affecting some
health outcomes, understanding the links between SEP and hor-
mones could help to identify if some population groups may be
especially vulnerable to unwarranted pharmacological hormone
supplementation (eg, of testosterone among older men(Gan et al.,
2013)).
Both material and psychosocial explanations for health in-
equalities (Bartley, 2008) could potentially be partly mediated by
endocrine function, although the robustness of the links between
hormones and material and psychosocial factors are uncertain.
For example, some studies have found that health-impacting be-
haviours such as physical activity are related to sex hormones (eg,
lower testosterone among women), (Rinaldi et al., 2014) while
other studies have reported null associations (Sowers et al., 2001).
Similarly, psychosocial factors such as stress and adverse life
events have been found to relate to higher cortisol concentrations
in some(Gerritsen et al., 2010) but not all studies (Ockenburg et al.,
2015). Most existing studies have found that indicators of lowersocioeconomic position are related to circulating hormone con-
centrations, including lower testosterone among men,(Zarotsky
et al., 2014) higher testosterone among women (Cappola et al.,
2007), lower IGF-I (Kumari et al., 2008), or higher cortisol
(Castro-Diehl et al., 2014; Desantis et al., 2015; Franz et al., 2013;
Kumari et al., 2010a; Miller et al., 2009). Most studies have
examined cortisol, with some studies ﬁnding lower SEP was
associated with lower cortisol,(Dowd et al., 2011; Groffen et al.,
2015) and others ﬁnding lower SEP was associated with a less
steep diurnal decline in cortisol (Desantis et al., 2015; Groffen
et al., 2015; Karlamangla et al., 2013; Kumari et al., 2010a) While
these separate studies suggest that SEP may be related to an
adverse hormone proﬁle across multiple endocrine axes, this re-
quires conﬁrmation in a single population study, particularly
given null ﬁndings in some studies (Yeap et al., 2012). Existing
studies have examined hormone measures at a single time point,
leading to uncertainty in the relations between SEP and the age-
related change in endocrine function. Most have used single in-
dicators of SEP in adulthood (such as education or income),
leading to further uncertainty as to the period/s of life in which
SEP may inﬂuence the endocrine system. Of the studies which
have examined SEP in childhood, relations have been found with
IGF-I and cortisol, suggesting that SEP in both early and adult life
may be important for subsequent endocrine axes (Franz et al.,
2013; Gustafsson et al., 2010; Kumari et al., 2008; Miller et al.,
2009). There may be cumulative adverse effects of low SEP
across life on endocrine axes if socioeconomically patterned risk
factors have independent effects on endocrine outcomes. For
example, childhood SEP may capture exposure to early life stress,
poor nutrition and growth, which may go on to affect endocrine
function in later life independent of adult risk factors (Bann et al.,
2014a; Ben-Shlomo et al., 2005; Gerritsen et al., 2010; Pearce
et al., 2011).
In this study, we examined associations between several in-
dicators of SEP (ascertained prospectively across life) with mul-
tiple components of the endocrine system, and hypothesised that
lower SEP across life would be associated with an adverse hor-
mone proﬁle across multiple axes. We choose to examine three
related endocrine pathways which we felt are likely to play an
integrated role in growth, maturational development, reproduc-
tion and responsiveness to stressors. From an evolutionary
perspective the ability to respond to adverse environmental cir-
cumstances would require more rapid growth, early reproductive
capacity and mobilisation of metabolic resources. Both animal
studies and limited human evidence suggest inter-play between
the stress and reproductive axis with development being a crucial
intermediary step in survival (Fitzgerald et al., 1996; Macadams
et al., 1986; Robert M Sapolsky, 1985; Robert M. Sapolsky, 2005).
We tested our hypotheses using data from a British birth cohort
study which beneﬁts from measures of the reproductive (testos-
terone), somatotrophic (insulin-like growth factor-I, IGF-I), and
stress axis (cortisol). Data for testosterone and IGF-I were also
obtained at two time points in midlife and early old age. We hy-
pothesized that lower SEP across life would be associated with
lower testosterone among men and higher testosterone among
women and, in both sexes, with lower IGF-I, higher night time
cortisol, and larger age-related declines in testosterone and IGF-I.
These relations would be consistent with inequalities in health
outcomes previously identiﬁed in this cohort. For example, lower
SEP has been related to increased risk of premature mortality,(Kuh
et al., 2002) biomarkers for cardiovascular disease risk,(Jones
et al., 2015) higher fat mass (and abdominal fat distribution)
(Bann et al., 2014a), and lower physical and cognitive capability
(Hurst et al., 2013).
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2.1. Study sample
The MRC National Survey of Health and Development (NSHD) is
a socially stratiﬁed sample of 5362 singleton births that took place
in one week of March 1946 in mainland Britain; All births from
women with husbands in non-manual and agricultural employ-
ment were included, and a random selection of one in four births to
females with husbands in manual employment (Wadsworth et al.,
2003). The cohort has been followed-up a total of 24 times across
life, with hormone data derived from blood samples at 53 and
60e64 years. At 60e64 years, 2856 eligible study members were
invited for an assessment at one of six clinical research facilities
(CRF) or a home visit. Invitations were not sent to those who had
died (n ¼ 778), who were living abroad (n ¼ 570), had previously
withdrawn from the study (n ¼ 594) or who had been lost to
follow-up (n ¼ 564). Of those invited, 2229 were assessed: 1690
attended a CRF and the remaining 539 were seen at home (Kuh
et al., 2011). Due to an increased likelihood of premature mortal-
ity (Kuh et al., 2002) and loss to follow-up (Stafford et al., 2013a),
those of lower SEP were less likely to participate in this wave. The
study received Multi-Centre Research Ethics Committee approval
and informed consent was provided by participants.
2.2. Blood and saliva sampling, and hormone measurement
The standardized blood sampling and measurement of testos-
terone (Bann et al., 2015), IGF(Bann et al., 2014b) and cortisol
(Kirschbaum and Hellhammer, 1989; Stafford et al., 2013b) in the
NSHD have been described in detail elsewhere and are brieﬂy
outlined below.
At 53 years, non-fasting venous blood samples were taken in
EDTA tubes during home visits by research nurses in the morning
(27%), afternoon (30%), or evening (43%). These were posted over-
night to a laboratory where plasma was extracted and frozen
at 80 C. At 60e64 years, overnight fasting venous blood samples
were obtained in citrate tubes, mostly in themorning (93% between
7.30am and 10am). These were then taken immediately to a labo-
ratory in each CRF or posted overnight to a CRF (home visit) and
plasma extracted before being frozen at 80Cdplasma samples
were transported between laboratories on dry ice to prevent
thawing. Plasma samples for both 53 and 60e64 years were
assayed during the same period.
IGF-1, IGF-II, and IGFBP-3 were measured from plasma samples
at 53 and 60e64 years using radioimmunoassay. Intra-assay COV
were 3.4% (IGF-I), 2.8% (IGF-II), and 3.9% (IGFBP-3); inter-assay COV
were 13.7% (IGF-I), 7.4% (IGF-II), and 11.7% (IGFBP-3). The remaining
plasma samples from 53 to 60e64 years were then assayed for
testosterone, using liquid chromatographyemass spectrometry,
and its binding protein, sex-hormone binding globulin (SHBG) us-
ing immunoassay (inter-assay COVs both <5.4%). Since sizable
proportions of circulating testosterone are chemically bound to
SHBG, and not able to affect target tissue, free testosterone was
calculated using the formula described by Vermeulen et al
(Vermeulen et al., 1999). Because testosterone varies diurnal-
lydconcentrations are substantially higher in themorning than the
afternoon or evening (P < 0.05)dwe estimated morning testos-
terone concentrations at 53 years for all participants to aid
comparability with 60e64 year samples (Bann et al., 2015). This
was achieved by constructing sex-speciﬁc regression models with
testosterone at 53 years as the outcome and time of blood collec-
tion as a categorical exposure; the model residuals were then
added to mean morning testosterone concentration for those who
gave blood samples in the afternoon and evening. Unliketestosterone, IGF-I concentrations did not differ according to the
timing of the blood sample (P ¼ 0.85).
At 60e64 years, cortisol was measured using radioimmuno-
assay of saliva samples(Kirschbaum and Hellhammer, 1989) ob-
tained in the evening (9e9.30pm), and at usual waking and 30 min
after the following day. Participants were asked not to drink 30min
before providing the sample and not smoke, eat, or brush their
teeth until after all samples were provided. Intra- and inter assay
coefﬁcients of variation were below 10%. Due to protocol changes,
cortisol was not measured in the ﬁrst clinical assessment (N¼ 230).
Participants who reported taking steroids at 60e64 years were
excluded from analyses (n¼ 15), as were thosewith outlying values
(<or > 4 SDs from the mean, N ¼ 23).
2.3. Socioeconomic position across life
Indicators were selected a-priori to capture SEP across life.
Paternal occupational class at 4 years was used as an indicator of
childhood SEP (the Registrar General's classiﬁcation (RGSC) con-
sisting of 6 standard categoriesdI professional, II intermediate, III
skilled non-manual, III skilled manual, IV semi-skilled, and V un-
skilled. Highest educational level achieved by 26 years was classi-
ﬁed using the Burnham scale(Department of Education and Science
(1972)): 1) no qualiﬁcations, 2) CSE, clerical course or equivalent, 3)
O level or equivalent (age 16 years), 4) A level or equivalent (age 18
years), and 5) Degree or higher (Department of Education and
Science (1972)) Two other measures of adult SEP were used:
highest household occupational class at 53 years (RGSC of the
participant or their partner) and, aftermost participants had retired
(~61%), self-reported household income at 60e64 years were used
to ascertain contemporaneous SEP (post-tax from all sources in 13
bands from per year: £6000 to 30000).
2.4. Analytical strategy
We conducted main analyses using a single circulating hor-
mones measure from each axis which we expected to be most
closely related to health and functional outcomes in older age: free
testosterone, IGF-I, and evening cortisol; associations with total
testosterone, SHBG, IGF-II and IGFBP3, and other cortisol measures
(morning concentration and diurnal drop) are presented in
supplementary tables.
We examined crude estimates of association by calculating
average hormone concentrations at 60e64 years by SEP categories,
and by examining associations between each SEP indicator and
each hormone using linear regression. Medians were used due to
the right-skew of some hormone measures. To facilitate compari-
sons of the associations across different SEP indicators, slope
indices of inequality (SII) were then used,(Mackenbach and Kunst,
1997) which account for differences in the distribution of partici-
pants across categories of different SEP indicators. Each indicator
was converted into sex-speciﬁc ridit scores; these range from 0 to 1,
with each SEP category given a value equivalent to the proportion
of the population with higher SEP than the midpoint of that cate-
gory. These ridit scores were then used as exposures in linear
regression modelsdthe coefﬁcients represent the absolute differ-
ence in outcome when comparing those with the hypothetically
lowest (1) with hypothetically highest SEP (0) (Mackenbach and
Kunst, 1997). To aid the interpretation of effect sizes, all hormone
measures were converted into standard deviation scores (z-scores);
measures which were right-skewed (testosterone in women, and
cortisol in both sexes) were ﬁrst log-transformed. To examine
whether SEP across life was cumulatively associated with hor-
mones, we examined associations with a lifetime SEP score, created
by summing all SEP ridit scores and dividing by 4 (so that the scales
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models were examined and compared with models examining
single SEP indicators with respect to statistical signiﬁcance (using
likelihood ratio test comparisons with the null model) and model
ﬁt (using Akaike Information Criterion (AIC)). Lower AIC values
indicate an improved model ﬁt, yet there are no well-established
cut-points for determining the extent to which an improved
model ﬁt is large, moderate, or small. As both low and high hor-
mone concentrations could indicate impaired endocrine regulation,
we also examined whether SEP was associated with both high and
low hormone concentrations; SEP indicators were cross-tabulated
with hormones categorized as the lowest 12.5%, middle 75%, and
highest 12.5%, and separate logistic regression models were con-
ducted to test associations between SEP with risk of both low and
high hormone concentrations.
To examine whether SEP was related to an adverse hormone
proﬁle acrossmultiple axes, we created a composite hormone score
(Cappola et al., 2009). This was calculated by converting hormone
measures into binary scores; a score of 1 was given if participants
were in the lowest quartile for IGF-I or the highest quartile for
evening cortisol. Men in the lowest quartile of free testosterone
were also given a score of 1, while women in the highest quartile
were given a score of 1 given evidence for sex-divergent effects of
testosterone (Brand et al., 2011). These scores, ranging from 0 (most
optimal hormone proﬁle) to 3 (most adverse proﬁle), were then
cross-tabulated with SEP indicators, and used as an outcome in
ordered logistic regression models. The proportional odds
assumption was tested using a likelihood ratio test to compare
constrained and unconstrained models.
For the hormones measured repeatedly (IGF and testosterone),
we also examined whether SEP up to 53 years (and a lifetime SEP
score up to 53 years) was associated with hormone concentrations
at 53 years and with calculated changes in hormone concentrations
between 53 and 60e64 years.
Because the determinants of hormone concentration may differ
by sex,(Parekh et al., 2010) we conducted all analyses separately in
men and women, and formally tested sex by SEP interaction terms.
Given evidence for sex differences in some associations with
testosterone and IGF-I (P < 0.05), we stratiﬁed main analyses
examining these hormones by sex. Deviation from linearity was
also assessed using likelihood ratio tests. Sample sizes (male/fe-
male) for each hormone at 60e64 years were as follows: 865/888
for testosterone, 875/905 for IGF-I, and 835/943 for cortisol. Ana-
lyses were restricted to participants with valid data for the SEP
indicator/s used and each hormonemeasure. Missing outcome data
was attributable to a number of reasons including insufﬁcient
plasma samples (IGF and testosterone data were measured after
other biochemical assays) and procedural and technical issues. In
addition, cortisol was not measured in the ﬁrst clinical assessment
facility (N ¼ 230), and some participants did not provide a blood
sample (n ¼ 86). The statistical package Stata (Stata Corporation,
Texas, USA) was used for all analyses.
2.5. Additional and sensitivity analyses
To examine whether the categorization of hormones affected
associations between SEP and the composite hormone score, ana-
lyses were repeated using different cut-points to categorize the top
or bottom 15% of each hormone, instead of 25%. To examine the
extent to which the use of estimated morning testosterone levels
(age 53 years) for participants who gave samples in the afternoon
or evening impacted on ﬁndings, additional analyses were con-
ducted using raw testosterone values in which the time of blood
sampling was not accounted for. Finally, to examine whether
missing data affected ﬁndings, we conducted additional analysesusing i) multiple imputation and ii) full information maximum
likelihood estimation.
3. Results
Men had higher free testosterone and IGF-I concentrations at
60e64 years than women, while there was no evidence for a sex
difference in evening cortisol (P ¼ 0.7; Table 1). Mean free testos-
terone and IGF-I concentrations were lower at 60e64 than at 53
years in both men and women, as previously described (Bann et al.,
2014b, 2015). Among both sexes, there was variation in the number
of adverse hormone concentrations observed (in men: 0 ¼ 45.9%
1 ¼ 37.4%, 2/3 ¼ 16.7%; women: 0 ¼ 43.7%, 1 ¼ 41.0%, 2/3 ¼ 15.3%).
Those with missing hormone data differed with respect to their
socioeconomic proﬁledthey were more likely to have been of
lower SEP (P < 0.01 for all SEP indicators and outcomes). Correla-
tions between the different hormone outcomes were weak-
dcortisol was not associated with IGF-I or free testosterone (r < 0.1
in both sexes), and IGF-I and free testosterone were weakly posi-
tively correlated (r ¼ 0.1 in men and 0.2 in women).
3.1. Testosterone
Among men, lower education and lower income were associ-
ated with lower testosterone at 60e64 years, while childhood SEP
and occupational class were not associated (Tables 1 and 2). For
example, results suggested a 0.37 (95% CI: -0.61, -0.12) standard
deviation lower free testosterone concentration in those with
lowest compared with highest educational attainment. In contrast,
among women lower childhood SEP was associated with higher
testosterone (p for sex interaction ¼ 0.01), while other indicators
were not associated. Models including single indicators of SEP
(income in men and childhood SEP in women) provided a better
model ﬁt (lower AIC) than a model using the lifetime SEP score,
suggesting little evidence for a cumulative association.
3.2. IGF-I
Lower educationwas associatedwith lower IGF-I at 60e64 years
amongmen (Tables 1 and 2), while other indicators and the lifetime
SEP score were not signiﬁcantly associated. Among women, lower
education and income were associated with lower IGF-I, and a
model using a lifetime SEP score provided the best model ﬁt
(marginally), suggesting a cumulative association between lower
SEP across life and lower IGF-I. For example, results suggested
a 0.59 (0.95, -0.22) standard deviation lower IGF-I amongst
those with lowest compared with highest socioeconomic position
across life.
3.3. Cortisol
A lower lifetime SEP score was associated with higher evening
cortisol at 60e64 years (b ¼ 0.32 (95% CI: 0.07e0.56;
AIC ¼ 4245.7)), but this model had a slightly higher AIC than the
model solely examining education (b ¼ 0.22 (0.05e0.39);
AIC ¼ 4244.6). However, in both relative and absolute terms, the
AIC was only marginally smaller. Other indicators of SEP weremore
weakly associated with higher evening cortisol, and 95% CIs over-
lapped with the null.
3.4. Composite adverse hormone score across multiple axes
Cross-tabulations and logistic regression results indicated no
evidence that SEP was associated with either low or high hormone
concentrations (data available on request).
Table 1
Hormone concentrations at 60e64 years by indicators of socioeconomic position across life.
N (M/F) Free testosterone (pmol/L)
Median (IQR)
IGF-I (ng/ml) Median (IQR) Cortisol (evening; nmol/L) Median (IQR)
Men Women Men Women Both sexes
Total sample 875/905 235.0 (87.4) 7.4 (5.3) 179.0 (74.8) 158.0 (75.2) 2.41 (2.13)
P (t-test) <0.001 <0.001
Paternal occ class (4y)
I professional 65/64 242.1 (98.9) 7.1 (4.8) 173.0 (48.6) 144.2 (59.7) 2.18 (2.15)
II intermediate 155/164 234.2 (72.8) 7.3 (5.0) 179.0 (77.1) 171.4 (74.3) 2.45 (2.17)
III skilled (Non-Manual) 167/182 235.3 (73.2) 7.1 (5.0) 185.7 (77.1) 159.4 (69.5) 2.46 (2.17)
III skilled (Manual) 242/244 233.1 (96.7) 7.2 (5.4) 170.4 (80.2) 158.6 (82.0) 2.54 (2.08)
IV partly skilled 163/157 230.2 (86.8) 8.2 (5.6) 183.9 (74.6) 152.0 (72.3) 2.34 (2.11)
V unskilled 44/47 251.2 (95.2) 8.2 (6.3) 195.0 (85.2) 153.4 (84.3) 2.54 (1.95)
P (trend) 0.37 <0.01 0.18 0.08 0.08
Own education (26y)
Degree or higher 155/55 246.9 (79.1) 6.6 (5.9) 180.3 (66.2) 165.2 (90.1) 2.28 (2.42)
GCE A level 256/256 234.4 (88.8) 7.5 (4.7) 185.6 (72.7) 169.3 (82.8) 2.31 (1.98)
GCE O level 125/229 236.1 (94.5) 7.3 (5.0) 178.0 (74.8) 153.6 (68.4) 2.53 (2.39)
Sub GCE O-level 46/84 234.2 (63.2) 8.6 (5.6) 186.0 (86.5) 149.9 (84.7) 2.49 (2.43)
No qualiﬁcations 245/238 230.2 (94.5) 7.7 (6.0) 165.4 (77.4) 156.3 (70.9) 2.48 (2.10)
P (trend) <0.01 0.91 <0.01 <0.01# 0.02
Occupational class (53y)
I professional 137/91 240.1 (67.5) 6.9 (5.0) 186.0 (58.0) 155.2 (57.7) 2.35 (2.21)
II intermediate 425/444 235.0 (92.8) 7.1 (5.2) 175.0 (73.1) 162.0 (76.0) 2.37 (1.99)
III skilled (Non-Manual) 164/211 225.3 (78.9) 8.0 (6.0) 189.3 (73.3) 159.3 (82.3) 2.46 (2.27)
III skilled (Manual) 104/74 243.6 (89.1) 8.4 (5.6) 159.7 (88.0) 146.3 (85.2) 2.44 (2.17)
IV partly skilled 29/48 235.7 (95.0) 8.0 (4.5) 144.7 (84.4) 145.1 (65.7) 2.73 (2.79)
V unskilled 8/10 250.1 (98.8) 6.4 (3.6) 183.9 (66.0) 128.7 (67.4) 3.35 (3.87)
P (trend) 0.56 0.30 0.09 0.02 <0.01
Household income (60e64y)
1 (highest) 322/238 247.5 (89.5) 7.2 (4.8) 182.8 (72.8) 163.4 (79.5) 2.36 (2.14)
2 209/212 233.9 (73.4) 7.5 (5.6) 177.6 (77.4) 170.9 (71.7) 2.37 (1.93)
3 197/242 231.1 (98.7) 7.4 (5.6) 177.0 (81.2) 156.7 (77.0) 2.40 (2.06)
4 (lowest) 102/159 222.5 (82.7) 7.5 (5.3) 175.5 (75.6) 146.0 (68.1) 2.53 (2.59)
P (trend) <0.001 0.42 0.21 <0.01 0.06#
Sample sizes presented for IGF-I, and differ for testosterone (865/888) and cortisol (835/943), and by SEP indicator used; #p(heterogeneity) shown due to non-linearity
(P < 0.05); log-transformed cortisol values used to calculated P-values due to right-skew; income displayed in 4 categories here to aid interpretation.
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score followed the same pattern as associations with its individual
components (Fig. 1). Lower SEP in childhood (more strongly in
women than men (P(sex interaction) ¼ 0.12)), lower education,
lower occupational class, and lower household income were asso-
ciated with higher adverse hormone scores. For example, in the
lowest compared with highest education, the odds of having 1
additional adverse hormone concentration was 3.67 (95% CI: 2.13,
6.31) among men, and 1.59 (0.95, 2.67) among women (P (sex
interaction) ¼ 0.02). There was little evidence for deviation fromTable 2
Estimated standard deviation differences in hormone concentrations (95% CI) at 60e64
index of inequality).
Free testosterone
(752 men, 745 women)
P AIC IGF-I (
758 w
Men
Paternal occ. class (4y) 0.10 (0.34, 0.14) 0.40# 2102.7 0.14 (
Own education (26y) 0.37 (0.61, 0.12) <0.01# 2099.1 0.40
Occupational class (53y) 0.11 (0.36, 0.15) 0.41 2103.8 0.23
Household income (60e64y) 0.42 (0.66, 0.19) <0.01# 2092.7 0.17
Lifetime SEP score 0.45(0.79, 0.11) 0.01# 2097.6 0.27
Women
Paternal occ. class (4y) 0.29 (0.08, 0.50) <0.01 1944.2 0.22
Own education (26y) 0.14 (0.08, 0.35) 0.21 1948.9 0.40
Occupational class (53y) 0.15 (0.07, 0.38) 0.18 1947.2 0.25
Household income (60e64y) 0.08 (0.-13, 0.29) 0.45 1949.2 0.32
Lifetime SEP score 0.38 (0.05, 0.71) 0.02 1945.1 0.59
#P-value for sex interaction term <0.05; sexes combined for cortisol due to a lack of evid
and derived using the Registrar General's classiﬁcation; Analyses using lifetime SEP score (
and each hormone.the proportional odds assumption (p-values from likelihood ratio
tests all >0.15), or for deviation from linearity in the above models.
3.5. SEP across life and estimated mid-life decline in IGF-I and
testosterone
SEP was not signiﬁcantly related to testosterone at 53 years
among men, while among women only low childhood SEP was
related to higher testosterone at 53 years (b ¼ 0.61, 95 CI: 0.31,
0.92); Table 3. However, SEP was not signiﬁcantly related to changeyears between the hypothetical lowest and highest socioeconomic position (slope
760 men,
omen)
P AIC Cortisol (evening)
(736 men, 780 women)
P AIC
Both sexes
0.09, 0.38) 0.23# 2130.8 0.10 (0.07, 0.27) 0.24 4250.6
(0.65, 0.16) <0.01 2124.6 0.22 (0.05, 0.39) 0.01 4244.6
(0.49, 0.02) 0.07 2129.6 0.17 (0.01, 0.34) 0.06 4249.1
(0.40, 0.07) 0.17 2131.5 0.15 (0.01, 0.32) 0.07 4249.1
(0.62, 0.08) 0.13 2130.9 0.32(0.07, 0.56) 0.01 4245.7
(0.46, 0.02) 0.07 2162.2
(0.64, 0.15) <0.01 2154.6
(0.50, 0.01) 0.06 2160.5
(0.55, 0.09) <0.01 2156.9
(0.95, 0.22) <0.01 2154.1
ence for sex interaction; occupational class was that of the highest in the household
and all AIC calculations) were restricted to those with valid data for all SEP indicators
Fig. 1. Socioeconomic position in relation to a composite hormone score at 60e64 yearsdodds ratios (95% CI) of being in a 1-unit higher (adverse) hormone proﬁle score in the
lowest compared with highest socioeconomic position (relative index of inequality). Note: men shown in circles, women in triangles. Hormone proﬁle scores were calculated by
adding together the number of adverse hormone concentrations recorded at 60e64 years (0, 1, 2e3). A score of 1 was given if participants were in the lowest quartile for either IGF-
I, or free testosterone concentration (among men onlydamong women those in the highest quartile were given a score of 1), or the highest quartile of evening cortisol con-
centration. Odds ratios were calculated using ordered logistic regression. Sample sizes were as follows: paternal occupational class (648 men, 682 women), education (638/690),
occupational class (670/703), household income (656/689), and lifetime SEP score (601/609); #p-value for sex interaction term <0.05.
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men, lower education and occupational class were more weakly
associatedwith lower IGF-I at 53 years, compared with associations
with IGF-I at 60e64 years. Among women, only lower occupational
class was signiﬁcantly associatedwith lower IGF-I at 53 years. There
was little evidence that SEP was associated with change in IGF-I
between 53 and 60e64 years in either men or women.
3.6. Additional and sensitivity analyses
Associations between SEP and total testosterone were similar to
those with estimated free testosterone (supplementary table 1).
Lower SEP was weakly and not-signiﬁcantly associated with lower
SHBG and lower IGF-II, and lower income was associated with
lower IGFBP3 in both sexes; indicators of SEP were generally not
associated with morning cortisol or diurnal drop (supplementary
table 1). Conclusions did not differ when categorizing adverse
hormone concentrations as being in the 15% (rather than 25%)
highest or lowest hormone concentrations, when not adjusting for
time of blood collection time at 53 years, nor when either usingTable 3
Estimated standard deviation differences in free testosterone and insulin like growth f
between the hypothetical lowest and highest socioeconomic position (slope index of ine
N Testosterone, 53y P
Men
Paternal occ. class (4y) 417 0.03(0.28, 0.23) 0.83
Own education (26y) 415 0.13(0.39, 0.13) 0.33
Occupational class (53y) 436 0.18(0.44, 0.09) 0.20
Lifetime SEP score 400 0.20(0.54, 0.14) 0.25
Women
Paternal occ. class (4y) 526 0.61(0.31, 0.92) <0.001
Own education (26y) 528 0.08(0.23, 0.39) 0.63
Occupational class (53y) 538 0.09(0.42, 0.23) 0.58
Lifetime SEP score 499 0.41(0.02, 0.83) 0.06
N IGF-I, 53y P
Men
Paternal occ. class (4y) 719 0.08(0.16, 0.32) 0.52
Own education (26y) 713 0.25(0.50, 0.00) 0.05
Occupational class (53y) 746 0.24(0.50, 0.02) 0.07
Lifetime SEP score 692 0.25(0.58, 0.08) 0.14
Women
Paternal occ. class (4y) 760 0.21(0.47, 0.05) 0.12
Own education (26y) 767 0.16(0.43, 0.10) 0.23
Occupational class (53y) 783 0.37(0.64, 0.10) <0.01
Lifetime SEP score 719 0.37(0.74, 0.00) 0.05
D calculated as 60e64y minus 53y hormone concentration; occupational class was that ofmultiple imputation or full information maximum likelihood esti-
mation to account for missing data on SEP indicators.4. Discussion
4.1. Main ﬁndings
In a nationally representative British birth cohort study assessed
in late midlife, we found evidence that lower levels of some in-
dicators of SEP were associated with an adverse hormone proﬁle
across multiple axes: with lower testosterone in men and higher
testosterone in women, and with lower IGF-I and higher evening
cortisol in both sexes. However, associations found with each hor-
mone differed by SEP indicator used and sex; among women our
data suggested a cumulative association between lower SEP across
life and lower IGF-I, while there was no strong evidence for accu-
mulation in associations with testosterone or cortisol. Associations
between SEP and hormones were particularly pronounced when
using a composite adverse hormone score.actor-I (IGF-I) concentrations at 53, 60e64 years, and change between these ages,
quality).
Testosterone, 60e64y P D Testosterone P
0.21(0.46, 0.04) 0.10 0.18(0.52, 0.16) 0.30
0.46(0.71, 0.20) <0.001 0.29(0.64, 0.06) 0.10
0.34(0.60, 0.08) 0.01 0.13(0.49, 0.23) 0.48
0.49(0.82, 0.15) <0.01 0.23(0.68, 0.22) 0.32
0.33(0.05, 0.61) 0.02 0.11(0.29, 0.07) 0.23
0.09(0.19, 0.37) 0.54 0.05(0.13, 0.24) 0.56
0.17(0.13, 0.47) 0.27 0.11(0.08, 0.30) 0.25
0.34(0.06, 0.73) 0.09 0.01(0.25, 0.24) 0.96
IGF-I, 60e64y P D IGF-I P
0.12(0.14, 0.37) 0.37 0.02(0.24, 0.28) 0.88
0.35(0.61, 0.08) 0.01 0.05(0.31, 0.22) 0.73
0.30(0.57, 0.02) 0.03 0.01(0.29, 0.27) 0.94
0.26(0.61, 0.09) 0.14 0.04(0.31, 0.38) 0.84
0.28(0.53, 0.03) 0.03 0.04(0.29, 0.21) 0.77
0.43(0.68, 0.17) <0.01 0.20(0.46, 0.06) 0.13
0.27(0.54, 0.00) 0.05 0.13(0.14, 0.40) 0.35
0.56(0.91, 0.20) <0.01 0.11(0.47, 0.25) 0.54
the highest in the household and derived using the Registrar General's classiﬁcation.
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Findings from this study add to the previous evidence relating
SEP to single hormone axes. For example, separate analyses have
shown that lower SEP is associated with lower testosterone among
men,(Zarotsky et al., 2014) higher testosterone among women,(-
Cappola et al., 2007) lower IGF-I,(Kumari et al., 2008) or higher
cortisol concentrations (Castro-Diehl et al., 2014; Desantis et al.,
2015; Franz et al., 2013; Kumari et al., 2010a; Miller et al., 2009).
We extend these ﬁndings by: better characterising the relations
between SEP and hormones in a well-characterised representative
birth cohort study; examining multiple hormones from different
axes; using repeat measures of IGF-I and testosterone; and by using
multiple indicators of SEP ascertained prospectively across life
which enabled us to test for cumulative associations. Our ﬁndings
add to the understanding of how SEP relates to biological processes
which are thought to partly underlie the ageing process and its
adverse consequences. These ﬁndings are broadly consistent with
previous evidence from this cohort which has identiﬁed socioeco-
nomic inequalities in health-related outcomes which may be partly
explained via an inﬂuence on the endocrine system (Bann et al.,
2014a; Hurst et al., 2013; Jones et al., 2015; Diana Kuh et al., 2002).
4.3. Explanation of ﬁndings
Associations between SEP and multiple hormones indicate the
socioeconomic patterning of the lifetime determinants of the
endocrine systems. The hormones investigated are known to be
tightly regulated by a series of homeostatic mechanisms (feed-
back loops)dthe presence of associations suggests that socio-
economically patterned risk factors may have affected the
homeostatic set-points by which typical hormone concentrations
are maintained, and/or affected the regulation of the homeostatic
mechanisms. These risk factors may be both shared across
different axes and/or affect only single hormone outcomes. For
example, lower SEP is related to higher fat mass levels,(Bann et al.,
2014a) which in turn may lead to lower IGF-I,(Bann et al., 2014b)
lower testosterone in men and higher testosterone in women
(Bann et al., 2015). In contrast, higher fat mass has been found to
be non-linearly associated with cortisol (Kumari et al., 2010b).
Other factors which may lie on the pathway between SEP and
hormones may be health-impacting behaviours such as physical
activity, diet, and smoking, exposure to stress and adverse events,
age at menopause,(Hardy and Kuh, 2005) and incidence of clini-
cally deﬁned and sub-clinical ill health. Early life SEP may be
related to hormones due to the persistence of socioeconomic
conditions across life since low childhood SEP typically limits
opportunities with respect to educational attainment, occupation,
income and wealth. Childhood SEP may also capture the inﬂuence
of childhood exposures which have persisting effects on hor-
mones independent of subsequent SEP. For example, childhood
milk intake has been related to adult IGF-I concentrations in old
age,(Ben-Shlomo et al., 2005) and exposure to stress in both early
and adult life has been related to adult cortisol concentrations
(Gerritsen et al., 2010). Delineating the relative contributions of
these different pathways is likely to be challenging given the
potential for bi-directionality in associations between many risk
factors and hormones (eg, between lower testosterone and ill
health). Although we hypothesized that the principal direction of
association was from SEP to hormones, it is possible that associ-
ations may be explained by reverse causality, or be bi-directional
in nature. For example, systemic disease may lead to lower
testosterone in men,(Karagiannis and Harsoulis, 2005) which
could in turn limit future occupational and earning opportunities,
and thereby confound associations between SEP with subsequenthormone outcomes. Reverse or bi-directionality is however less
likely to explain the prospective associations found between
childhood SEP and subsequent hormones, as the childhood SEP
measures used (ascertained at 4 years) preceded the hormone
measures by up to 60 years. Confounding by genetic factors which
affect both circulating hormones and socioeconomic outcomes
may also have a role in explaining our ﬁndings, although hor-
mones (and socioeconomic factors) are known to be affected by
environmental factors (Ben-Shlomo et al., 2005; Cappola et al.,
2007; Parekh et al., 2010).
Associations between SEP indicators and testosterone among
men were stronger (and more signiﬁcant) at 60e64 years than at
53 years. This may suggest that the socioeconomic patterning of
endocrine function determinants may become especially pro-
nounced at older ages. However, associations of SEP with changes
in testosterone and IGF-I were not signiﬁcant. These may reﬂect
true null ﬁndings or lack of power as the age-related decline will
be partially masked by measurement error and regression to the
mean, particularly when only 2 time points are available (Singer
and Willett, 2003). Further studies are required with more
frequently repeated samples to better characterise these dynamic
relationships in later decades. Differences in the strength and
signiﬁcance of association between each SEP indicator and hor-
mones may be explained by differences in the extent to which
each SEP indicator relates to the above intermediary risk fac-
torsdeach captures information during particular periods of life,
and in different aspects of the socioeconomic environment. For
example, among men educational attainment was more strongly
associated with fat mass at 60e64 years in this cohort than
paternal occupational class,(Bann et al., 2014a) potentially
explaining its stronger association with testosterone and IGF-I.
Among men, lower income was most strongly related to lower
testosterone, while among women only lower childhood SEP was
related to higher testosterone. These ﬁndings suggest that aspects
of contemporaneous SEP in older age and/or factors related to
adulthood material circumstances may have especially impacted
on testosterone concentrations in men, whilst in women devel-
opmental inﬂuences may have impacted on long term testos-
terone concentrations. Contrary to expectation, we did not ﬁnd
strong evidence that childhood SEP was associated with other
outcomes. This could indicate that contemporaneous adult so-
cioeconomic circumstances are stronger determinants of the
hormone concentrations investigated, potentially due to the
combined inﬂuence of material, behaviours, and/or psychosocial
pathways. Lower education was most strongly related to higher
evening cortisol, suggesting that factors especially related to ed-
ucation may have impacted on cortisol concentrations. Alterna-
tively, education may have simply been the most relevant marker
of SEP across life, as it reﬂects both childhood experiences and
subsequent employment, income, and wealth opportunities
(Galobardes et al., 2006). Indeed, education has been considered a
‘fundamental cause’ of health inequality, since the links between
education and health have persisted despite changes over time in
the beneﬁts which a higher education attainment provides
(Montez and Friedman, 2015). Taken together, our ﬁndings sug-
gest that studies using single indicators of SEP may provide an
incomplete understanding of how SEP impacts on endocrine
function. Although this warrant future consideration, caution is
needed when interpreting associations with multiple SEP in-
dicators, as some results could reﬂect chance ﬁndings as multiple
statistical tests have been carried out; the interpretation of results
may be more appropriately focused on the overall patterns of
estimated associations (and corresponding conﬁdence intervals)
rather than the signiﬁcance level of each speciﬁc association
examined.
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Strengths of this study include the availability of prospectively
ascertained SEP indicators obtained across life and multiple hor-
mone measures, some of which were repeated. While multiple
different SEP indicators were used which have been found to relate
to health-related outcomes in this cohort, other research may be
required to more comprehensively examine which dimensions of
SEP are most closely related to endocrine functioning (eg, with
respect to education, occupational class, income, or wealth). As in
all longitudinal studies, loss to follow-up occurred which reduced
statistical power and may have introduced bias. Speciﬁcally, study
members with lower SEP and worse functional health were less
likely to participate at 60e64 years, through death or attrition
(Cooper et al., 2014; Stafford et al., 2013a). If those lost to follow-up
also had especially unfavourable hormone proﬁles, this pattern of
missing data may have weakened the observed associations be-
tween SEP and hormones; in other cases, missing data could have
led to strengthening of the observed relationships. Sample sizes for
repeat testosterone measures were limited by the numbers of
remaining stored serum samples. However, the loss in sample size
and power may have been partly offset by the comparatively higher
accuracy and precision of the mass-spectroscopy assays
useddunlike immunoassay, mass spectroscopy has sufﬁcient
sensitivity to accurately quantify the low testosterone levels among
women (Gallagher et al., 2007; Thienpont et al., 2008).
Because of day-to-day andweek-to-week variability in hormone
concentrations, the single blood (and one-day saliva) sample
measures obtained at each age imperfectly captured long-term
concentrations. Assuming that this source of error was random, it
would have led to less precise estimates of association between SEP
and hormones, particularly where COV were higher (eg, for IGF-I).
In addition, the limited number of cortisol measures used are
likely to have imperfectly captured the true diurnal variability in
cortisol which may be more closely related to SEP and health
outcomes. However, other studies have found that cortisol mea-
sures in the NSHD relate to physical function and social isolation,
suggesting that the measures do have moderate-good convergent
validity (Gardner et al., 2013; Stafford et al., 2013b). Methodological
differences in blood sampling at 50 and 60e64 years (eg, non-
fasting samples at 53 years obtained across the day) may have
impacted on the results examining change in hormones, although
we found little evidence that accounting for blood sample time
affected ﬁndings. Although we investigated multiple hormones in
this study, only IGF and testosterone were measured at two ages, as
such we were unable to examine how SEP related to change in
cortisol during age. In order to fully understand how SEP relates to
change in hormone measures during the ageing process, more
repeated measurements are clearly required, spanning early and
later life. Aside from the measures included in this study, other
hormones may also be important for health and function in older
age, and may therefore warrant future investigation. For example,
estrogen was not measured in the NSHD, precluding its investiga-
tion here despite its potential importance for health among women
(Corbelli et al., 2015; Herrera and Mather, 2015). Measures of thy-
roid function are also likely to warrant future investigation: lower
SEP has been related to increased hyperthyroidism risk,(Wilson
et al., 2006) which may in turn predict adverse health, although
the prevalence of hyperthyroidism was low in the NSHD at 60e64
years (1.7%) (Pierce et al., 2012). We used a composite score to
describe the number of adverse hormone concentrationsdsimilar
composite scores have been shown to be more strongly related to
frailty risk than single hormone measures,(Cappola et al., 2009;
Hertoghie, 2005) but they are clearly simpliﬁcations of a dy-
namic, interactive endocrine system, and their construction ispartly dependent on the hormones measured in each study. If as-
sociations between exposures and hormone outcomes are inde-
pendent of other hormones, it would be expected that associations
with a composite hormone outcomewould be stronger. However, it
should be noted that there is no accepted standard method to
either deﬁne or measure multiple adverse hormone concentra-
tions, nor conceptual phenomena such as dysregulation (Ferrucci
and Studenski, 2012). Further developments may enable more
detailed characterisation of endocrine function across multiple
axes, including the use of dynamic measures which arguably have
more relevance to biological function than single measures of
circulating concentrations.4.5. Implications
Findings from this study suggest that those of lower SEP may be
at higher risk of having adverse hormone concentrations across
multiple axes in late midlife. These associations may in turn partly
underlie socioeconomic inequalities in a range of health and
functional outcomes in older age as the endocrine system has been
hypothesised as being a key modulator of the ageing process
(Chahal and Drake, 2007; Ferrucci and Studenski, 2012; Hertoghie,
2005). Future studies are needed to empirically test these medi-
ating pathways. While the identiﬁcation of underlying biological
mechanisms may help us to better understand the effects of SEP
across life and help strengthen causal inferences, mechanistic un-
derstanding is not a prerequisite for successful interventiondthere
is increasing evidence that interventions targeting the up-stream
socioeconomic factors are more efﬁcacious in reducing socioeco-
nomic inequalities in health than those which target intermediary
factors (Lorenc et al., 2013).
The relative importance of these and other hormones in human
ageing is currently uncertain. While IGF-I and testosterone have
been observed to decline with age, and be related to health and
functional outcomes, important heterogeneity exists, with some
studies not ﬁnding expected associations between testosterone,
IGF-I or cortisol(Singh-Manoux et al., 2014; Stenholm et al., 2010)
and health-related outcomes. This, in addition to potential publi-
cation bias which could favour signiﬁcant relations between hor-
mones and health-related outcomes in observational studies,
suggests that future experimental and observational studies are
needed to help delineate the relative importance of hormonal
systems for the ageing process and its consequences.4.6. Conclusions
In a British birth cohort study, lower SEP was associated with an
adverse hormone proﬁle in late midlife age across multiple axes
(lower testosterone among men, higher testosterone among
women, and with lower IGF-I and higher evening cortisol in both
sexes). Associations with individual hormones differed by SEP in-
dicator and sex. Further studies are required to better characterize
how SEP relates to age-related changes in endocrine function, and
to examine the functional relevance of associations found.Conﬂict of interest
Nothing to declare.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.socscimed.2015.11.001.
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